Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancer.
Ammu V V V Ravi KiranGarikapati Kusuma KumariPraveen Thaggikuppe KrishnamurthyPublished in: Investigational new drugs (2021)
Preliminary results revealed that pioglitazone adjunacy with celecoxib may be an effective chemo-preventive agent against NNK induce NSCLC.